The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Survey

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

EuroIntervention 2020;16:247-250. DOI: 10.4244/EIJ-D-20-00528

1. Division of Cardiology, University Hospitals, Geneva, Switzerland; 2. Division of Cardiology, CAST, P.O. “G. Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy; 3. Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland; 4. Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, Barts Heart Centre, London, United Kingdom; 5. Yale University School of Medicine, New Haven, CT, USA; 6. Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland; 7. Maria Cecilia Hospital GVM, Cotignola, Ravenna, Italy


Introduction

COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), has imposed an unprecedented burden on healthcare systems worldwide. While guidance on management of cardiovascular conditions in the setting of COVID-19 is being gathered, little is known about the effects of the pandemic on interventional cardiology practice [1]. The first reports originating from highly affected areas describe a reduction in the number of patients presenting to the emergency department (ED) with acute coronary syndromes (ACS) [2,3]. In order to shed light on the impact of the COVID-19 pandemic on the management of patients encountered in routine interventional ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Screening for transcatheter mitral valve replacement: a decision tree algorithm